Drug Profile
Velusetrag - Theravance Biopharma
Alternative Names: TD-5108Latest Information Update: 31 Mar 2023
Price :
$50
*
At a glance
- Originator Theravance
- Developer Alfa Wassermann SpA; Alfasigma; Theravance Biopharma
- Class Antidementias; Azabicyclo compounds; Gastrokinetics; Laxatives; Small molecules
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Intestinal obstruction
- Discontinued Alzheimer's disease; Constipation; Gastroparesis